This guideline focuses on managing prolactin-secreting pituitary adenomas in adults, excluding pregnancy. The panel recommends cabergoline as the first-choice pharmacological treatment, with bromocriptine as an alternative for intolerant patients. Medication and surgery are suggested as suitable...